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Background: Ventricular septal defects (VSDs) are the most common congenital car-
diac defect in horses.
Objectives: To identify prevalence, age, breed, and sex distribution of VSD and to
describe associated clinical and ultrasonographic findings.
Animals: Hospital-based population of 21 136 horses presented to the equine inter-
nal medicine department.
Methods: Medical records over a 12-year period were reviewed for VSD confirmed
by ultrasonography. Age, breed, sex, sport discipline, murmur, clinical signs, outcome,
VSD type, VSD size, shunt velocity, cardiac dimensions, concomitant cardiac anoma-
lies, and valvular regurgitations were recorded.
Results: From 1894 horses that underwent echocardiography, 54 had a VSD: 42 as
an isolated lesion and 12 as part of complex congenital heart disease (CHD). Median
age was 5 years (range, 0-26) and 1 year (range, 0-8), respectively. Warmbloods and
males were overrepresented. In the isolated VSD group, only 15% had associated
clinical signs and most horses had a perimembranous VSD (pmVSD; 36/42). Horses
with a pmVSD and clinical signs showed a significantly lower maximal shunt velocity
(3.77 vs 5.20 m/s; P < .001), higher VSD/Aortic root (Ao) diameter (0.52 vs 0.38;
P = .05), higher left atrium/Ao diameter (1.94 vs 1.22; P < .001), and higher pulmo-
nary artery/Ao diameter (1.15 vs 0.88; P = .005) compared to horses without clinical
signs. All horses with complex CHD had clinical signs and abnormal cardiac
dimensions.
Conclusion and Clinical Importance: Most isolated VSD were diagnosed only at a
later age and were not associated with clinical signs. Horses with complex CHD were
more likely to have or develop clinical signs at younger age.
Abbreviations: Ao, aorta; AoV, aortic valve; ASD, atrial septal defect; CHD, congenital heart disease; infVSD, infundibular ventricular septal defect(s); LA, left atrium; LADd, left atrial diameter at
end-diastole; LADs, left atrial diameter at systole; LVID, left ventricular internal diameter at end-diastole; LVOT, left ventricular outflow tract; muscVSD, muscular ventricular septal defect(s); PA,
pulmonary artery; PDA, patent ductus arteriosus; pmVSD, perimembranous ventricular septal defect(s); PV, pulmonary valve; RVOT, right ventricular outflow tract; TV, tricuspid valve; VSD,
ventricular septal defect.
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1 | INTRODUCTION
Ventricular septal defects (VSDs) are the most common congenital
cardiac defect in horses,1-5 with an increased prevalence in certain
breeds such as Standardbreds, Welsh Mountain ponies, and Arabian
horses.1,5,6,7 They may occur in conjunction with other congenital
cardiac malformations as part of complex congenital heart disease
(CHD)5 although they also may occur as an isolated defect. Congenital
cardiac malformations occur secondary to errors during cardiac
development,3 and have different consequences depending on the
extent of anomaly, leading to variable clinical signs. In contrast to
humans,8 the heritability of VSD in horses is unknown, but affected
horses should be considered unsuitable for breeding.7 To make a
diagnosis, ultrasonographic sequential segmental analysis9 is rec-
ommended to identify unusual arrangement of the cardiac chambers
and major arteries, and altered topographic cardiovascular anatomy. It
is not uncommon for isolated VSD to be diagnosed at a later age. Lit-
erature is scarce regarding case series of congenital cardiac defects,
especially isolated VSD.1,2,5 The purpose of this retrospective study
was to identify the prevalence, age, breed, and sex distribution of
VSD as an isolated defect and as part of a complex congenital anom-
aly, to describe the associated cardiac murmur and to correlate the
ultrasonographic characteristics of the VSD with cardiac dimensions,
clinical signs, and sport discipline, in an equine internal medicine hos-
pital population over a 12-year period (2008-2019).
2 | MATERIAL AND METHODS
Medical records from horses, admitted to the Large Animal Internal
Medicine Department of Ghent University between 2008 and 2019,
were reviewed. The breed and sex distribution of the entire popula-
tion was recorded. For each horse with an ultrasonographic diagnosis
of VSD, age, breed, sex, sport discipline (pleasure riding, dressage, or
jumping), and outcome (discharged or euthanasia after diagnosis) were
obtained. Clinical signs and heart murmurs at the time of VSD diagno-
sis and electrocardiographic and echocardiographic findings, including
measurements and presence of concomitant structural abnormalities,
were recorded. All owners were contacted 1 to 12 years after initial
examination and follow-up data were obtained.
2.1 | Echocardiography and color flow Doppler
examination
Sequential segmental analysis9 was used to identify the presence of a
VSD with or without other congenital cardiac malformations. Standard
2-dimensional (2D), color flow Doppler and continuous wave Doppler
examinations together with continuous electrocardiographic record-
ing10 were obtained by trained observers using a dedicated ultrasono-
graphic unit (GE Vivid 7 Dimension, Vivid IQ or Vivid E95, GE
Healthcare, Diegem, Belgium). Oblique views from multiple angles
were taken to optimize visualization of congenital defects. Data were
digitally stored and off-line analysis was performed using dedicated
software (Echopac version BT12 or 203, GE Medical System, Diegem,
Belgium). The images were reassessed by a single person (G. van Loon,
Dip. ECEIM, assoc. member ECVDI, PhD) for this study.
Horses were divided into 2 groups, depending on the presence of
an isolated VSD or a VSD as part of complex CHD. Horses with CHD
without simultaneous presence of a VSD were not included in the
study.
The VSD type was recorded as perimembranous (pmVSD), infun-
dibular (infVSD), or muscular (muscVSD). The VSD long-axis and
short-axis size was measured from 2D images (Figures 1 and 2) and
the average of both values was used in ratio calculations. Maximal
shunt velocity (Vmax) was obtained by continuous wave Doppler and
the pressure gradient was calculated using the modified Bernoulli
equation.11 Color flow, pulsed wave and continuous wave Doppler
were used to diagnose shunting of blood. The end-systolic aortic and
left atrial (LA) diameter were measured using the right parasternal
short-axis view at aortic valve (AoV) level to obtain the VSD/aortic
root diameter ratio (VSD/Ao) and left atrial/aortic root diameter ratio
(LA/Ao). The end-systolic pulmonary artery (PA) diameter was mea-
sured using the right parasternal left ventricular outflow tract (LVOT)
view and the pulmonary artery/Ao root diameter ratio (PA/Ao) was
F IGURE 1 An isolated perimembranous ventricular septal defect
(pmVSD), viewed from a right parasternal left ventricular outflow
image, shows discrete bulging of the sinus of Valsalva (arrow) and the
opened aortic valve cusp (arrowhead) into the defect. The double
arrow shows the pmVSD longitudinal diameter. Ao, aorta; LV, left
ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle
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calculated. The left atrial diameter, parallel with the mitral valve, was
measured at end-systole (LADs) and end-diastole (LADd) using a right
parasternal 4-chamber view. End-diastolic left ventricular internal
diameter at chordal level (LVIDd) was measured using an M-mode
from a right parasternal short-axis view or from a long-axis 4-chamber
view. All valves were evaluated for structural abnormalities and regur-
gitation, using different scanning planes and color flow Doppler. Aor-
tic valve prolapse was diagnosed when a distinct inflection point from
the natural curve of the sinus of Valsalva was found and part of the
base of the cusp was dragged into the defect.12,13 Prolapse of the
AoV was assessed using a right parasternal LVOT view for a pmVSD
and using a right parasternal right ventricular outflow tract (RVOT)
view and left parasternal cranial view of pulmonary valve (PV) and PA
for an infVSD. Dextroposition with override of the aortic root and
right ventricular (RV) hypertrophy were subjectively identified on the
right parasternal LVOT view and 4-chamber view, respectively. Steno-
sis of the PV was morphologically identified, including abnormal valve
structure, abnormal valve opening, and abnormal annulus diameter
using the right parasternal RVOT view and confirmed using a left par-
asternal view of the RVOT and PA. Continuous wave Doppler maxi-
mal flow velocity (Vmax; m/s), maximal pressure gradient (Pmax;
mm Hg), and pulmonic velocity time integral (cm) were used to iden-
tify flow across the stenotic valve. A patent ductus arteriosus (PDA)
was identified using the right parasternal RVOT view or left par-
asternal long-axis view of the PA with its bifurcation.14 To confirm
the diagnosis, systolic or continuous flow between aorta and PA was
documented by color flow Doppler. An atrial septal defect (ASD) was
identified by angling the ultrasound beam in multiple directions from a
right and left parasternal approach. Shunting of blood through the
defect was confirmed by color flow Doppler.
When horses were admitted for reevaluation, examinations were
repeated as mentioned above.
2.2 | Data analysis
Normality of all variables was graphically assessed using Q-Q plots.
Within the group of pmVSD, a multivariate analysis of variance (SPSS
Statistics 26) was used to compare VSD average diameter, Vmax,
VSD/Ao, LA/Ao, PA/Ao, LADs, LADd, and LVIDd between
horses with and without clinical signs. P values ≤.05 were considered
significant.
3 | RESULTS
3.1 | General characteristics of the study sample
During the 12-year study period, 21 136 horses were admitted to the
Department of Large Animal Internal Medicine, and consisted of 60%
males (25% stallions) and 60% Warmbloods. Only 7% were racehorses
(5% Trotters and 2% Thoroughbreds). Six percent of the entire study
sample were younger than 1 month and 89% were older than
6 months. Almost all underwent cardiac auscultation. Nine percent
(1894/21136) received an echocardiographic examination. Fifty-four
(54/1894; 2.9%) horses had a VSD confirmed by echocardiography
and their median age was 5 years (range, 0-26). None of the horses
had >1 VSD. Forty-two of the horses with VSD (78%) had no other
congenital cardiac anomaly, whereas 12 horses (22%) had a VSD com-
bined with another cardiac malformation (ASD, dextroposition with
override of the aortic root, RV hypertrophy, pulmonary stenosis, PDA,
tricuspid valve [TV] atresia). In the entire equine internal medicine
patient population, this resulted in a prevalence of 0.2% (42/21136)
for isolated VSD and 0.05% (12/21136) for VSD in combination with
other cardiac anomaly.
3.2 | Characteristics of the isolated VSD
The median age at presentation for these 42 horses was 5 years
(range, 0-26), 67% were males (38% stallions) and 60% were
Warmbloods. Only 1 Thoroughbred and 1 Trotter were present in the
VSD population. Twenty-nine horses had a right-sided (grade 3/6 to
6/6) and 8 a left-sided (grade 4/6 to 6/6) pansystolic murmur with a
holosystolic murmur on the contralateral side. Three horses had a
holosystolic murmur on the right and left side and in 2 the murmur
type had not been documented. In 3 horses (3/42), atrial fibrillation
was present. On echocardiography, 86% (36/42) of the horses with
an isolated VSD had a pmVSD (Figure 3, Video S1) of which 64%
(23/36) had AoV prolapse into the defect (Figure 4, Video S2), which
was associated with AoV regurgitation in 79% of those cases (19/23)
and with a diastolic murmur on auscultation in 26% (6/23). Ten per-
cent (4/42) had an infVSD and 4% (2/42) a muscVSD. Detailed infor-
mation can be found in Table 1. Only 15% (6/42) of the isolated VSD
horses showed clinical signs such as dullness, poor body condition
score, poor growth, chronic diarrhea, tachypnea, fever, ventral edema,
or jugular vein pulsation. Seventy-one percent (30/42) exercised on a
F IGURE 2 Short-axis view of the perimembranous ventricular
septal defect, adjacent to the commissure of the right and
noncoronary cusp, of the same horse as in Figure 1. The sinus of
Valsalva (arrow) and opened aortic valve cusp (arrowhead) are shown.
The double arrow shows the pmVSD short-axis diameter. Ao, aorta;
LA, left atrium; pmVSD, perimembranous ventricular septal defect
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regular basis, most of them for jumping, dressage, or pleasure riding.
Of the 3 horses with atrial fibrillation, 2 had clinical signs with left and
right heart dilatation. In the third horse, only the left heart was mark-
edly dilated.
Within the group of pmVSD, horses with and horses without clin-
ical signs showed a significantly different Vmax (3.77 vs 5.20;
P < .001), VSD/Ao (0.52 vs 0.38; P = .05), LA/Ao (1.94 vs 1.22;
P < .001), and PA/Ao (1.15 vs 0.88; P = .005), respectively (Table 2).
Within the same group, no significant difference was found between
horses with and without clinical signs in pmVSD diameter (2.80 vs
2.18; P = .37), LADs (11.0 vs 10.8; P = .88), LADd (10.2 vs 9.82;
P = .8), and LVIDd (12.4 vs 10.7; P = .25). Concerning the pmVSD
group with clinical signs, 1 horse had a small VSD diameter, but also
had a chordal rupture, a severely dilated left heart and PA, and lung
edema. In the pmVSD group without clinical signs, 6 horses had a
pmVSD diameter >3 cm, of which 5 had AoV prolapse that decreased
the size of the shunt (Figure 4).
For the horses with infVSD (4/42; Figure 5), the average infVSD
diameter in 2 horses was 1.75 cm and 3.60 cm and the VSD/Ao was
0.36 cm and 0.57 cm, respectively. In the third horse, only a short-axis
diameter was available, which was 2.6 cm. The average maximal shunt
velocity of all 3 was 4.02 ± 0.59 m/s (range, 3.36-4.48 m/s). In 1 Draft
horse, no measurements could be obtained because of insufficient
image quality. One horse with an infVSD had clinical signs and was
simultaneously diagnosed with AoV prolapse in the defect (Video S3)
and subsequent valve tear.
Concerning the horses diagnosed with a muscVSD (2/42;
Figure 6), average VSD diameter was 0.9 and 1.1 cm, maximal shunt
velocity 4.18 and 6.15 m/s and VSD/Ao ratio 0.18 and 0.20, respec-
tively. None of them had clinical signs.
Eighty-one percent (34/42) of the horses with an isolated VSD
were discharged. Four horses with a pmVSD and 1 with an infVSD
could be followed over several years. Echocardiography was repeated
6 months (1 horse) or approximately 1 year (4 horses) after diagnosis.
In addition, 3 were re-evaluated 3 to 4 times over the 3 to 5 years
after initial diagnosis. In all 5 horses, VSD diameter and Vmax
remained similar at re-examination. In 3 of 4 horses with pmVSD and
AoV prolapse, mild to severe AoV regurgitation was diagnosed at ini-
tial examination and remained stable during follow-up examinations.
The fourth horse did not have AoV prolapse at the initial examination
but it developed 1 year after initial diagnosis. Three of the 4 horses
diagnosed with pmVSD continued their regular exercise (from recrea-
tional riding to 135 cm jumping).
Telephone contact 1 to 12 years after initial diagnosis allowed
follow-up information to be obtained in 62% of the cases. Twenty-six
percent of the horses followed-up exercised at recreational (low) level
exercise to more intense jumping competition on a regular basis with-
out noticeable exercise intolerance. One 8-year-old horse with addi-
tional severe mitral and tricuspid regurgitation and cardiomegaly, for
which it had been advised to no longer ride the horse, collapsed and
died during a forest walk. Twenty-nine percent of the horses were
euthanized within 3 years after initial diagnosis because of the VSD or
other health problems.
3.3 | Characteristics of the complex congenital
malformations
In 22% (12/54) of the horses with a VSD, the VSD was part of com-
plex CHD with the presence of ≥1 of the following abnormalities:
ostium primum ASD, dextroposition with override of the aortic root,
RV hypertrophy, pulmonary stenosis, PDA, and TV atresia. This
F IGURE 3 An isolated perimembranous ventricular septal defect
(arrow), viewed from a right parasternal left ventricular outflow image.
There is no prolapse of the aortic valve. Ao, aorta; LV, left ventricle;
PA, pulmonary artery; RA, right atrium; RV, right ventricle
F IGURE 4 A large isolated perimembranous ventricular septal
defect (pmVSD), viewed from a right parasternal left ventricular
outflow image in a 15-year-old warmblood horse. The marked bulging
of the sinus of Valsalva (arrows) into the defect reduces the VSD
shunt area but also causes aortic valve regurgitation. The double
arrow shows the pmVSD longitudinal diameter. Arrowheads indicate
the septal leaflet of the tricuspid valve. IVS, interventricular septum;
LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right
ventricle
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represents 0.6% (12/1894) of the population that underwent an echo-
cardiographic examination. Detailed information can be found in
Table 1. Eleven of the 12 horses had a pmVSD; 1 horse had a
muscVSD. The median age at presentation was 1 year (range, 0-8),
58% were males and 50% were Warmbloods. Two Arabians, 1 Arabian
cross-breed, 1 Draft horse, and 2 Welsh ponies were affected. No
racehorses were affected. Almost all horses had a left- and right-sided
systolic murmur ranging from holosystolic (grade 4-5/6) to pansystolic
(grade 4-5/6). Two also had a holodiastolic murmur. Murmur intensity
was highest on the right side of the thorax or similar on both sides. In
2 horses, the murmur was incompletely or not recorded. Two horses
had a continuous murmur associated with a PDA. One horse had AF
and tachycardia (>52 bpm) at rest was recorded in 7 horses. At the
time of examination, all horses had clinical signs, some more pro-
nounced than others. Nasal discharge, cough, tachypnea, dyspnea,
fever, collapse, mild colic, exercise intolerance, ventral edema, and jug-
ular vein pulsation were reported. In 4 cases, arterial oxygen tension
was measured and was decreased (range, 20-92 mm Hg). Three
horses (3/12) exercised on a regular basis, 1 of them frequently partic-
ipated in low level endurance competitions (40 km), but all of them
had exercise intolerance. The mean ± SD VSD diameter was
2.93 ± 1.44 cm, mean maximal shunt velocity 2.90 ± 0.88 m/s, and
mean VSD/Ao was 0.59 ± 0.13. Because of insufficient image quality
in a Draft horse, the VSD/Ao could not be calculated. In 2/12 horses,
no measurements of the left heart were obtained, whereas the left
heart was enlarged in 8/10. Eight of 12 horses had a VSD in combina-
tion with dextroposition with override of the aortic root (Figure 7,
Video S4), PV stenosis (Figure 8, Video S5), and RV hypertrophy, ful-
filling the criteria of tetralogy of Fallot (TOF), of which 4 had a dilated
PA. One of the TOF horses also was diagnosed with an ostium
TABLE 1 Breed, median age, sex, and ventricular septal defect type of the affected horses
Isolated VSD with clinical
signs (n = 6)
Isolated VSD without clinical
signs (n = 36)
VSD as part of complex congenital cardiac















1 Arabian x Friesian

















Abbreviations: n, number of horses; VSD, ventricular septum defect(s).
TABLE 2 Mean, SD, and P value of horses with and without clinical signs within the isolated perimembranous ventricular septal defect
(pmVSD) group
Isolated pmVSD with clinical signs (n = 5) Isolated pmVSD without clinical signs (n = 30a) P value
VSD diameter (cm) 2.80 ± 0.75 2.18 ± 0.90 .37
Vmax (m/s) 3.77 ± 0.70 5.20 ± 0.61 <.001
VSD/Ao 0.52 ± 0.1 0.38 ± 0.13 .05
LA/Ao 1.94 ± 0.54 1.22 ± 0.14 <.001
PA/Ao 1.15 ± 0.25 0.88 ± 0.16 .005
LADs (cm) 11.00 ± 1.52 10.80 ± 2.48 .88
LADd (cm) 10.15 ± 1.05 9.82 ± 2.57 .8
LVIDd (cm) 12.38 ± 1.60 10.71 ± 2.73 .25
Note: P values ≤.05 were considered statistically significant.
Abbreviations: Ao, aorta diameter; LA, left atrium; LADd, left atrial diameter at end-diastole; LADs, left atrial diameter at end-systole; LVIDd, end-diastolic
left ventricle internal diameter; n, number; PA, pulmonary artery diameter; Vmax, maximal VSD shunt velocity.
aNo measurements were available from one Draft horse due to poor image quality.
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primum ASD and was referred to as pentalogy of Fallot. In almost all
horses with complex CHD (10/12), PV stenosis was present. In all, a
predominant left-to-right shunting of blood through the VSD was
found. Two horses had an ostium primum ASD and 1 also had TV
atresia, a cleft mitral valve, a VSD and a difference in left ventricle
(LV) and RV size, which was compatible with the diagnosis of atrio-
ventricular septal defect with tricuspid atresia and ventricular
imbalance.15
Ten horses (10/12) were euthanized and 2 were discharged.
Despite the advice not to ride both discharged horses, 1 died during
recreational exercise several weeks after diagnosis.
4 | DISCUSSION
In this retrospective study, we describe 54 horses presented with
VSD as an isolated defect or as part of a CHD. Most cases were iso-
lated pmVSD, often with AoV prolapse into the defect. In this pre-
dominant non-racehorse population, most were Warmbloods and
males with a median age of 5 years old (range, 0-26). All horses had
loud, widely radiating cardiac murmurs. Concerning the isolated
pmVSD, most horses (85%) did not have any clinical signs and
exercised on a regular basis in contrast to horses affected with com-
plex CHD. In the latter population, some had a tetralogy of Fallot and
F IGURE 5 Left parasternal cranial view of the pulmonary valve in
a 3-year-old Warmblood horse shows an infundibular septal defect
(arrows) ventral to the pulmonary valve, connecting left (LV) and right
(RV) ventricle. IVS, interventricular septal defect; PA, pulmonary
artery
F IGURE 6 A right parasternal short-axis view near the ventricular apex (cranial to the right) without (left) and with (right) color flow Doppler.
The small muscular ventricular septal defect is difficult to visualize on 2D because it is located ventrally and near the junction of septum and free
wall. With color flow Doppler the systolic turbulent flow (green) into the right ventricle can be identified. LV, left ventricle; RV, right ventricle
F IGURE 7 A right parasternal left ventricular outflow view shows
right ventricular hypertrophy, a large perimembranous ventricular
septal defect and dextroposition with override of the aortic root in
this horse with Tetralogy of Fallot. Ao, aorta; LA, left atrium; LV, left
ventricle; PA, pulmonary artery; RV, right ventricle
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almost all were euthanized. In horses with an isolated pmVSD, a sig-
nificant difference was found in several ultrasonographic variables
between horses with and without clinical signs. Follow-up indicated
that 26% of the horses continued to exercise on a regular basis.
Although it has been reported that VSD often accompany more
complicated malformations,5 in our population only 22% of the VSD
were associated with another cardiac malformation. This represents a
prevalence of 0.05% of the entire referred equine internal medicine
hospital population (21 136 horses) over a 12-year period. In the liter-
ature, a prevalence of 0.1% to 0.5% has been reported for congenital
cardiac anomalies in general.5 Previous studies1 reported a high preva-
lence of VSD in Standardbreds and Arabians. In our study, isolated
VSDs were predominantly found in Warmbloods, which reflected the
breed distribution within our study sample. The mean age in our study
was higher than previously reported.1 Similar to an older study,1 more
horses with an isolated VSD were males, which also reflected the sex
distribution within our study sample. The group with complex CHD
included fewer males and fewer Warmbloods compared to the study
sample. All owners were advised not to breed their horses.
The phenotypic presentation in our study was the same as
reported in literature, with a pmVSD being most commonly
reported.1,3,4 Because color flow Doppler might slightly overestimate
the size of a defect, we chose to asses VSD size from 2D images
(Figures 1 and 2). Anatomically, the pmVSD (Figure 3, Video S1) is
located below the right and noncoronary cusp of the AoV and
encompassing or contiguous with the fibrous part of the inter-
ventricular septum.16,17 The infVSD, also called a “subpulmonic”
(Figure 5), “subarterial,” “supracristal,” “doubly committed,” or “juxta-
arterial” defect, is in fibrous continuity between the AoV and PV.3
Both the pmVSD and infVSD can be identified on ultrasonography
using standardized scanning planes.1,6,11 The muscVSD, also called
“trabecular defect,” is surrounded by muscular tissue.3 This VSD type
may be located anywhere along the interventricular septum and may
be difficult to identify. Based on our experience, it is useful to
examine the entire RV with color flow Doppler from long- and short-
axis planes to identify small defects, especially those located apically
or near the junction between septum and free wall (Figure 6).
As described in previous reports,1,4,6,11,18 in our study all isolated
VSD were associated with a harsh holo- or pan-systolic murmur on
the right or left or both thoracic sides. Concerning the pmVSD, the
murmur usually is loudest just below the TV region. In contrast, the
murmur of an infVSD is loudest cranially on the left side, below
the PV area, and a muscVSD may create a left- or right-sided systolic
murmur with a different radiation pattern.7,11,18 In our study, 64% of
the pmVSD cases had AoV prolapse (Figure 4, Video S2), which is
higher than the 25% previously reported.1,4,6,11 Factors such as breed,
anatomical position of the aorta in relation to other cardiac structures,
and better image quality today might have played a role in the high
prevalence of AoV prolapse identified in our study. In contrast to
human patients, AoV prolapse seemed to occur less frequently in
infVSD, but the numbers in our study were too small to draw conclu-
sions.12,13 Aortic valve prolapse usually involved part of the aortic
root. Indeed, also in human medicine, AoV prolapse is defined as a dis-
tinct inflection point from the natural curve of the sinus of Valsalva,
with part of the base of the cusp dragged into the defect.12,13,19,20
The AoV cusp is thin and mobile and especially vulnerable to be
drawn into the high-velocity low-pressure jet as blood shunts left to
right through the VSD. Over time, this can result in elongation of the
nadir of the adjacent AoV cusp and dilatation of the sinus of Valsalva
with outward and downward displacement of the aortic annulus. This
often will lead to a lack of coaptation between the AoV cusps,
resulting in AoV regurgitation.20 One should be aware that concurrent
presence of aortic regurgitation may result in more rapid deterioration
of cardiac function.
A pmVSD may lead to a discrete systolic murmur over the PV
area caused by relative pulmonary stenosis with occurrence of
turbulence.18
Small isolated VSD generally are well tolerated.7,18 Larger isolated
VSD lead to increased pulmonary flow and increased venous return to
the LA and LV. This eventually causes LA enlargement and LV dilata-
tion and eccentric hypertrophy.11 Literature mentions that horses
without clinical signs have pmVSD size <2.5 cm, maximal shunt veloc-
ity >4 m/s, and VSD/Ao <0.4,1 which was the case for most of our
horses without clinical signs. However, the pmVSD diameter was not
significantly different between horses with and without clinical signs.
This could be explained by the fact that a small VSD could be associ-
ated with clinical signs because of the presence of other important
cardiac abnormalities, such as severe acquired valvular regurgitation.
And on the other hand, several of the horses without clinical signs had
a relatively large defect that was restrictive because of AoV prolapse
into the defect, narrowing the actual shunt size. Nevertheless, some
horses without clinical signs showed lower shunt velocity compared
to the literature, a higher VSD/Ao ratio and increased LA, LV and PA
size without noticeable exercise intolerance. These horses were used
in less physically demanding sport disciplines, such as jumping, dres-
sage, or pleasure riding, in contrast to a previous study of racehorses.1
Our data therefore suggest that horses not engaged in racing may
F IGURE 8 A left parasternal cranial view of the pulmonary valve
shows marked pulmonary valve stenosis (double arrow). PA,
pulmonary artery; RV, right ventricle
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better tolerate larger VSDs. Also, increased cardiac chamber diameters
in some of the horses might have been a consequence of valvular
regurgitation rather than the septal defect. A few horses developed
atrial fibrillation, which was presumed to be secondary to atrial dilata-
tion. No ultrasonographic reference data, were found for infVSD or
muscVSD.
In people, spontaneous closure of a pmVSD by a thin layer of
fibrous tissue has been reported on rare occasions.21 Also, muscVSD
may close by apposition of the muscular borders of the VSD by mus-
cular in-growth and fibrous proliferation or by hypertrophy of the
myocardium. In 1 horse with a 1.09 cm muscVSD, the VSD could no
longer be identified on color flow Doppler when the horse was
25 months old.21 Spontaneous closure was not encountered in our
study, but not enough follow-up data were available to draw any con-
clusions. Our study only included CHD cases when they were associ-
ated with a VSD. In many case reports, CHD defects are fatal early in
life6 and the diagnosis is made at that time.5,14-22 In our study, horses
with complex CHD were younger than those with isolated VSD, but
still, half of them were >1 year old. An association between complex
CHD and the Arabian breed has been confirmed.5 In our study, most
horses were Warmbloods but the Arabian breed was underrepre-
sented in our overall internal medicine hospital population of 21 136
horses. As reported before and as seen in our study, foals affected
with complex CHD often have a loud systolic murmur with the point
of maximal intensity over the PV area.6
Some horses with complex CHD exercised on regular basis, 1 fre-
quently participated in low level endurance competitions and only had
mild exercise intolerance, an occasional cough and increased sweating.
Pulmonary valve stenosis may have an important effect on RV pres-
sure and volume overload, which is compensated for by RV hypertro-
phy, but also decreases Vmax of the shunt flow and limits PA and LA
volume overload.6 As such, a mild degree of stenosis actually may be
protective, and fewer clinical signs might be seen, than with a large
pmVSD.6
Eight horses were diagnosed with a Tetralogy of Fallot which
consists of RV outflow obstruction associated with a VSD,
dextroposition with override of the aortic root, and RV hypertrophy.
In human medicine,22 the term dextroposition of the aortic root is
used when a pathological rightward displacement of the aortic root is
present.22 This is in contrast to overriding of the aorta without
dextroposition, which can occur in an otherwise normal heart because
of a sigmoid interventricular septum or RV hypertrophy.22 One foal
did have a muscVSD together with a reversed PDA, which has been
described in a previous case report.23 Both recorded ASDs were
ostium primum ASDs, where the defect is situated in the ventral por-
tion of the atrial septum and above the inlet ventricular septum,15 and
an atrioventricular septal defect was diagnosed in 1 horse.
Our study had several limitations. Because the study consisted of
an internal medicine hospital population, it does not allow conclusions
to be drawn regarding the general horse population. Horses admitted
to other departments for reproduction and obstetrics, medical imaging
and orthopedics, and surgery and anesthesiology were not included.
The mean VSD size, as well as LA, and LV diameters were calculated
for all patients and included different breeds and ages, resulting in a
wide range. Especially for the complex CHD group, the mean VSD
diameter might have been underestimated because it included more
young animals compared to the isolated VSD group. Bubble studies
using injection of agitated saline, and measurement of hematocrit and
arterial oxygen saturation were only performed occasionally. Our
study focused on cardiac findings and does not allow conclusions to
be drawn regarding other noncardiac congenital abnormalities that
might have been associated with the CHD.
5 | CONCLUSION
Horses with a VSD as part of complex CHD are more likely to develop
clinical signs at a younger age. Isolated pmVSD are found most com-
monly. Size of the VSD and shunt flow velocity assist in judging their
clinical importance, but concomitant aortic regurgitation caused by
valvular prolapse in the defect complicates this judgment. Compared
to a racehorse population, this predominant Warmblood population
included horses without clinical signs with a larger isolated VSD size
and lower shunt flow velocity than previously reported. For infVSD
and muscVSD, no specific criteria currently exist to judge the effect
on performance.
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